The databook is designed to serve as a comprehensive guide to navigating this
sector. The databook focuses on market statistics denoted in the form of
revenue and y-o-y growth and CAGR across the globe and regions. A detailed
competitive and opportunity analyses related to liquid biopsy market will
help companies and investors design strategic landscapes.
blood sample was the
largest segment with a revenue share of
73.22% in
2023.
Horizon Databook has segmented the Global liquid biopsy market based on blood sample covering the revenue growth of each sub-segment from 2018 to
2030.
- Global Liquid Biopsy Type Outlook (Revenue, USD Million, 2018-2030)
- Global Liquid Biopsy Biomarker Outlook (Revenue, USD Million, 2018-2030)
- Circulating Tumor Cells (CTCs)
- Circulating Nucleic Acids
- Exosomes/ Microvesicles
- Circulating Proteins
- Global Liquid Biopsy Technology Outlook (Revenue, USD Million, 2018-2030)
- Multi-gene-parallel Analysis (NGS)
- Single Gene Analysis (PCR Microarrays)
- Global Liquid Biopsy Application Outlook (Revenue, USD Million, 2018-2030)
- Cancer
- Lung Cancer
- Prostate Cancer
- Breast Cancer
- Colorectal Cancer
- Leukemia
- Gastrointestinal Cancer
- Others
- Reproductive Health
- Others
- Global Liquid Biopsy End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals and Laboratories
- Specialty Clinics
- Academic and Research Centers
- Others
- Global Liquid Biopsy Clinical Application Outlook (Revenue, USD Million, 2018-2030)
- Therapy Selection
- Treatment Monitoring
- Early Cancer Screening
- Recurrence Monitoring
- Others
- Global Liquid Biopsy Product Outlook (Revenue, USD Million, 2018-2030)
- Instruments
- Consumables Kits and Reagents
- Software and Services
Reasons to
subscribe to Global liquid biopsy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of
Global liquid biopsy market databook
-
Our clientele includes a mix of liquid biopsy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed
overview of
global-level
data and insights on the Global liquid biopsy market , including
forecasts for subscribers. This
global
databook contains high-level insights into
Global liquid biopsy market from
2018 to
2030, including revenue
numbers, major trends, and company profiles.